Cargando…
The Nose Knows: Intranasal Midazolam To Treat Acute Seizures During Inpatient Epilepsy Monitoring
Autor principal: | Vossler, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818205/ https://www.ncbi.nlm.nih.gov/pubmed/32940057 http://dx.doi.org/10.1177/1535759720955167 |
Ejemplares similares
-
The Winner by a Nose: Intranasal Midazolam
por: Faught, Edward
Publicado: (2019) -
Forecasting Seizure Storms Using Epilepsy Wristband Sensors
por: Vossler, David G.
Publicado: (2021) -
Does SARS-CoV-2 Cause Seizures and Epilepsy in COVID-19 via Inflammation or by Direct Infection?
por: Vossler, David G.
Publicado: (2023) -
Midazolam, Ketamine, and Propofol: While We Slept, Others Worked on Anesthetizing Infusions for Refractory Status Epilepticus
por: Vossler, David G.
Publicado: (2023) -
Remarkably High Efficacy of Cenobamate in Adults With Focal-Onset Seizures: A Double-Blind, Randomized, Placebo-Controlled Trial
por: Vossler, David G.
Publicado: (2020)